Englander Institute for Precision Medicine

Immunological aspects of central neurodegeneration.

TitleImmunological aspects of central neurodegeneration.
Publication TypeJournal Article
Year of Publication2024
AuthorsNiso-Santano M, Fuentes JM, Galluzzi L
JournalCell Discov
Date Published2024 Apr 09

The etiology of various neurodegenerative disorders that mainly affect the central nervous system including (but not limited to) Alzheimer's disease, Parkinson's disease and Huntington's disease has classically been attributed to neuronal defects that culminate with the loss of specific neuronal populations. However, accumulating evidence suggests that numerous immune effector cells and the products thereof (including cytokines and other soluble mediators) have a major impact on the pathogenesis and/or severity of these and other neurodegenerative syndromes. These observations not only add to our understanding of neurodegenerative conditions but also imply that (at least in some cases) therapeutic strategies targeting immune cells or their products may mediate clinically relevant neuroprotective effects. Here, we critically discuss immunological mechanisms of central neurodegeneration and propose potential strategies to correct neurodegeneration-associated immunological dysfunction with therapeutic purposes.

Alternate JournalCell Discov
PubMed ID38594240
PubMed Central IDPMC11004155

Weill Cornell Medicine Englander Institute for Precision Medicine 413 E 69th Street
Belfer Research Building
New York, NY 10021